Eli Lilly and Co
SIX:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
SIX:LLY
|
US |
|
K
|
Kering SA
MIL:KER
|
FR |
|
E
|
Ecolab Inc
BMV:ECL
|
US |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
Vestas Wind Systems A/S
SIX:VWS
|
DK |
|
C
|
Compagnie Financiere Richemont SA
SWB:RIT1
|
CH |
|
3
|
3M Co
SIX:MMM
|
US |
|
F
|
Fortune Brands Home & Security Inc
F:2FB
|
US |
|
C
|
CoreCivic Inc
F:PSRA
|
US |
|
L
|
L'Oreal SA
DUS:LOR
|
FR |
|
B
|
Bureau Veritas SA
DUS:4BV
|
FR |
|
Global UAV Technologies Ltd
F:YAB
|
CA |
|
L
|
Lundin Mining Corp
F:GXD
|
CA |
|
S
|
S&P Global Inc
XMUN:MHL
|
US |
|
T
|
Toyota Motor Corp
XHAM:TOM
|
JP |
|
A
|
American Water Works Company Inc
SWB:AWC
|
US |
|
M
|
Microsoft Corp
XHAM:MSF
|
US |
|
S
|
Sea Ltd
SWB:931
|
SG |
|
Fugro NV
OTC:FUGRF
|
NL |
|
E
|
Ecolab Inc
F:ECJ
|
US |
|
T
|
Teck Resources Ltd
XMUN:TEKB
|
CA |
|
Shimano Inc
F:SHM
|
JP |
|
M
|
Masimo Corp
SWB:3M4
|
US |
|
T
|
TechnoPro Holdings Inc
OTC:TCCPY
|
JP |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 997.26 CHF with a low forecast of 702.47 CHF and a high forecast of 1 288.74 CHF.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
997.26
CHF
According to Wall Street analysts, the average 1-year price target for LLY is 997.26 CHF with a low forecast of 702.47 CHF and a high forecast of 1 288.74 CHF.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.
